Gregory H. Bailey - 18 Sep 2024 Form 4 Insider Report for Serina Therapeutics, Inc. (SER)

Role
Director
Signature
/s/ Steve Ledger, Attorney in Fact
Issuer symbol
SER
Transactions as of
18 Sep 2024
Net transactions value
+$88,257
Form type
4
Filing time
20 Sep 2024, 18:59:29 UTC
Previous filing
22 Aug 2024
Next filing
24 Sep 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SER Common Stock Purchase $16,873 +2,709 +5.7% $6.23 50,561 18 Sep 2024 Direct F1
transaction SER Common Stock Purchase $71,384 +11,679 +23% $6.11 62,240 19 Sep 2024 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reflects the weighted average purchase price of multiple transactions ranging from a low of $6.18 per share to a high of $6.25 per share. Upon the written request of the SEC, the issuer or a security holder of the issuer, the reporting person agrees to provide the number of shares sold at each sale price.
F2 The price reflects the weighted average purchase price of multiple transactions ranging from a low of $5.96 per share to a high of $6.25 per share. Upon the written request of the SEC, the issuer or a security holder of the issuer, the reporting person agrees to provide the number of shares sold at each sale price.